オピオイドの世界市場：2022年～2028年

世界のオピオイドの市場規模は、予測期間中にCAGRで3.5％の成長が予測されています。

市場の成長を後押ししている主な要因として、疼痛や下痢の蔓延が挙げられます。一方で、大麻（マリファナ）の合法化は、予測期間中の市場成長に悪影響を及ぼす要因となることが予想されます。

当レポートでは、世界のオピオイド市場について調査し、競合情勢、製品タイプ・用途別の市場セグメンテーション、地域分析、企業プロファイル等に関する情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
• ポーターの分析

第3章 競合情勢

• 主要企業分析
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の開発
• 主要戦略分析

第4章 市場セグメンテーション

• 世界のオピオイド市場：製品タイプ別
  • コデイン
  • フェンタニル
  • オキシコドン
  • メタドン
  • モルヒネ
  • ヒドロコドン
  • その他
• 世界のオピオイド市場：用途別
  • 疼痛管理
  • 咳治療
  • 下痢治療

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• その他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 企業プロファイル

• AstraZeneca Plc
• C.H. Boehringer Sohn Ag and Ko. Kg
• Endo Pharmaceuticals, Inc.
• Johnson & Johnson Services, Inc.
• Jupiter Pharmaceuticals, Ltd.
• Lupin, Ltd.
• Mallinckrodt Pharmaceuticals
• Midas Pharma GmbH
• Pfizer, Inc.
• Piramal Enterprises Ltd.
• Sanofi S.A.
• Sun Pharmaceutical Industries, Ltd.
• Taj Pharmaceuticals, Ltd.
• Teva Pharmaceutical Industries, Ltd.
• West-Ward Pharmaceuticals Corp.

LIST OF TABLES

• 1. GLOBAL OPIOIDS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
• 2. GLOBAL CODEINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 3. GLOBAL FENTANYL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 4. GLOBAL OXYCODONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 5. GLOBAL METHADONE S MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 6. GLOBAL MORPHINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 7. GLOBAL HYDROCODONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 8. GLOBAL OTHER OPIOIDS PRODUCT TYPE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 9. GLOBAL OPIOIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 10. GLOBAL OPIOIDS FOR PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 11. GLOBAL OPIOIDS FOR COUGH TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 12. GLOBAL OPIOIDS FOR DIARRHEA TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 13. GLOBAL OPIOIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 14. NORTH AMERICAN OPIOIDS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 15. NORTH AMERICAN OPIOIDS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
• 16. NORTH AMERICAN OPIOIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 17. EUROPEAN OPIOIDS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 18. EUROPEAN OPIOIDS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
• 19. EUROPEAN OPIOIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 20. ASIA-PACIFIC OPIOIDS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 21. ASIA-PACIFIC OPIOIDS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
• 22. ASIA-PACIFIC OPIOIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 23. REST OF THE WORLD OPIOIDS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 24. REST OF THE WORLD OPIOIDS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
• 25. REST OF THE WORLD OPIOIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL OPIOIDS MARKET SHARE BY PRODUCT TYPE, 2021 VS 2028 (%)
• 2. GLOBAL OPIOIDS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
• 3. GLOBAL OPIOIDS MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 4. GLOBAL CODEINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 5. GLOBAL FENTANYL MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 6. GLOBAL OXYCODONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 7. GLOBAL METHADONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 8. GLOBAL MORPHINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 9. GLOBAL HYDROCODONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 10. GLOBAL OTHER OPIOIDS PRODUCT TYPE MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 11. GLOBAL OPIOIDS FOR PAIN MANAGEMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 12. GLOBAL OPIOIDS FOR COUGH TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 13. GLOBAL OPIOIDS FOR DIARRHEA TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 14. US OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 15. CANADA OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 16. UK OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 17. FRANCE OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 18. GERMANY OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 19. ITALY OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 20. SPAIN OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 21. REST OF EUROPE OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 22. INDIA OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 23. CHINA OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 24. JAPAN OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 25. SOUTH KOREA OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 26. REST OF ASIA-PACIFIC OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)
• 27. REST OF THE WORLD OPIOIDS MARKET SIZE, 2021-2028 ($ MILLION)

Title:Global Opioids Market Size, Share and Trends Analysis Report, by Product Type (Codeine, Fentanyl, Oxycodone, Methadone, Morphine, Hydrocodone, and Others), by Application (Pain Management, Cough Treatment, and Diarrhea Treatment), Forecast Period (2022-2028).

The global opioids market is anticipated to grow at a CAGR of 3.5% during the forecast period. The major factors that are fueling the growth of the market include the growing prevalence of pain and diarrhea. Opioids are generally used for treating pain; however, opioid-containing drugs are being misused or are being consumed in overdose when patients follow self-medication. The opioid drug class comprises morphine, hydrocodone, oxycodone, heroin, codeine, morphine, fentanyl, and methadone. It is also employed as a cough suppressant and in diarrhea treatment. Opioids can be administered either through pills, liquids, intravenous, transdermal patches, or lozenges. Developed nations in North America and Europe have high levels of abuse of this drug. Drugs such as codeine, morphine, fentanyl, and hydrocodone have become a source of addiction, especially among the population, owing to the easy availability of drugs in these regions.

However, global organizations as well as regulatory agencies including the FDA, Centers for Disease Control and Prevention (CDC), and World Health Organization (WHO) are working towards restricting the abuse of opioids by creating awareness and educating prescribers to be cautious while prescribing these drugs. In recent years, cannabis has emerged as an alternative to opioids. Cannabis is legalized in many states in the US, as it is considered safer than opioids. Therefore, legalizing cannabis (marijuana) is a factor that is expected to have a detrimental impact on the market growth during the forecast period.

The global opioids market is segmented based on product type and application. Based on product type, the market is sub-segmented into codeine, fentanyl, oxycodone, methadone, morphine, hydrocodone, and others. Based on applications, the market is sub-classified into pain management, cough treatment, and diarrhea treatment. The pain management segment held the largest opioid market share and is expected to remain dominant during the forecast period. The segment growth is attributed to the rapid increase in the number of patients suffering from chronic headaches, migraine, and backaches; patients recuperating from surgery or undergoing severe pain associated with cancer. Rising sports and trauma injuries further drive the need for opioids for pain management.

Geographically, the opioids market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest market share. The factors such as the increasing number of product approvals by the regulatory authorities to meet the growing unmet medical needs in the region, the presence of strong healthcare infrastructure, and growing healthcare expenditure per capita boost regional growth.

The major market players in the global opioids market include AstraZeneca Plc, Pfizer Inc., Boehringer Ingelheim GmbH, and Sanofi S.A., Sun Pharmaceutical Industries Ltd., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global opioids market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.

• Whitepapers, research papers, and news blogs.

• Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

• Global Opioids Market Research and Analysis by Product Type
• Global Opioids Market Research and Analysis by Application

The Report Covers:

• Comprehensive research methodology of the global opioids market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global opioids market.
• Insights about market determinants that are stimulating the global opioids market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion
• 2.3. Porter's Analysis

3. Competitive Landscape

• 3.1. Key Company Analysis
  • 3.1.1. Overview
  • 3.1.2. Financial Analysis
  • 3.1.3. SWOT Analysis
  • 3.1.4. Recent Developments
• 3.2. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Opioids Market by Product Type
  • 4.1.1. Codeine
  • 4.1.2. Fentanyl
  • 4.1.3. Oxycodone
  • 4.1.4. Methadone
  • 4.1.5. Morphine
  • 4.1.6. Hydrocodone
  • 4.1.7. Others
• 4.2. Global Opioids Market by Application
  • 4.2.1. Pain Management
  • 4.2.2. Cough Treatment
  • 4.2.3. Diarrhea Treatment

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East & Africa

6. Company Profiles

• 6.1. AstraZeneca Plc
• 6.2. C.H. Boehringer Sohn Ag and Ko. Kg
• 6.3. Endo Pharmaceuticals, Inc.
• 6.4. Johnson & Johnson Services, Inc.
• 6.5. Jupiter Pharmaceuticals, Ltd.
• 6.6. Lupin, Ltd.
• 6.7. Mallinckrodt Pharmaceuticals
• 6.8. Midas Pharma GmbH
• 6.9. Pfizer, Inc.
• 6.10. Piramal Enterprises Ltd.
• 6.11. Sanofi S.A.
• 6.12. Sun Pharmaceutical Industries, Ltd.
• 6.13. Taj Pharmaceuticals, Ltd.
• 6.14. Teva Pharmaceutical Industries, Ltd.
• 6.15. West-Ward Pharmaceuticals Corp.